Journal: mBio
Article Title: ENO2 regulates CD4 + T cell pyroptosis via mitochondrial ROS to drive immunological non-response in HIV infection
doi: 10.1128/mbio.01702-25
Figure Lengend Snippet: Phosphoenolpyruvate supplementation was found to partially restore mitochondrial oxidative phosphorylation, reduce mitochondrial ROS level, and reduce pyroptosis in CD4 + T cells. ( A and B ) Negatively selected HIV-infected CD4 + T cells after ART were incubated with 10 µM ENOblock with or without 10 µM PEP for 24 h to detect mitochondrial respiratory capacity OCR (IR: n = 3, INR: n = 1). ( C and D ) Negatively selected ART-treated HIV-infected CD4 + T cells, 10 µM ENOblock was added, incubated with or without 10 µM PEP for 24 h to detect mitochondrial ROS (IR: n = 10, INR: n = 3) and levels of pyroptosis (IR: n = 20), typical flow charts are shown on the left, and the statistical graph of the percentage is shown on the right. ( E ) Caspase-1 expression on CD4 + T cells was assayed after knockdown of ENO2 in HIV-infected patients after ART with siENO2, accompanied by exogenous supplementation of PEP, with typical flow charts on the left and a statistical plot of the percent change in caspase-1 levels on the right ( n = 7). Data are analyzed by RM one-way ANOVA test in panel B ; Friedman test in panels C–E . **** P < 0.0001, *** P < 0.001, ** P < 0.01, and * P < 0.05.
Article Snippet: ENO2 was inhibited by the addition of 10 μM ENO2 inhibitor ENOblock (MCE), and anti-CD3/CD28 Dynabeads (Gibco) were added and incubated at 37°C for 24 h for flow cytometry.
Techniques: Phospho-proteomics, Infection, Incubation, Expressing, Knockdown